Decreased Microvascular Claudin-5 Levels in Cerebral Amyloid Angiopathy Associated with Intracerebral Haemorrhage

Overview

Journal Brain Pathol

Date 2024 May 19

PMID 38763889

Authors

Lieke Jakel

Kiki K W J Claassen

Anna M de Kort

Wilmar M T Jolink

Yannick Vermeiren

Floris H B M Schreuder

Benno Kusters

Catharina J M Klijn

H Bea Kuiperij

Marcel M Verbeek

Affiliations

Soon will be listed here.

Abstract

Decreased microvascular levels of claudin-5 in the occipital and temporal lobe of patients with cerebral amyloid angiopathy are associated with intracerebral haemorrhage.

Citing Articles

Decreased microvascular claudin-5 levels in cerebral amyloid angiopathy associated with intracerebral haemorrhage.

Jakel L, Claassen K, de Kort A, Jolink W, Vermeiren Y, Schreuder F Brain Pathol. 2024; 34(6):e13270.

PMID: 38763889 PMC: 11483184. DOI: 10.1111/bpa.13270.

References

Jakel L, Claassen K, de Kort A, Jolink W, Vermeiren Y, Schreuder F . Decreased microvascular claudin-5 levels in cerebral amyloid angiopathy associated with intracerebral haemorrhage. Brain Pathol. 2024; 34(6):e13270. PMC: 11483184. DOI: 10.1111/bpa.13270. View

Kozberg M, Yi I, Freeze W, Auger C, Scherlek A, Greenberg S . Blood-brain barrier leakage and perivascular inflammation in cerebral amyloid angiopathy. Brain Commun. 2022; 4(5):fcac245. PMC: 9576155. DOI: 10.1093/braincomms/fcac245. View

Magaki S, Tang Z, Tung S, Williams C, Lo D, Yong W . The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier. Neurobiol Aging. 2018; 70:70-77. PMC: 6146962. DOI: 10.1016/j.neurobiolaging.2018.06.004. View

Hashimoto Y, Greene C, Munnich A, Campbell M . The CLDN5 gene at the blood-brain barrier in health and disease. Fluids Barriers CNS. 2023; 20(1):22. PMC: 10044825. DOI: 10.1186/s12987-023-00424-5. View

Hartz A, Bauer B, Soldner E, Wolf A, Boy S, Backhaus R . Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke. 2011; 43(2):514-23. PMC: 5761312. DOI: 10.1161/STROKEAHA.111.627562. View

Freeze W, Jacobs H, Schreuder F, van Oostenbrugge R, Backes W, Verhey F . Blood-Brain Barrier Dysfunction in Small Vessel Disease Related Intracerebral Hemorrhage. Front Neurol. 2018; 9:926. PMC: 6240684. DOI: 10.3389/fneur.2018.00926. View

Yamazaki Y, Kanekiyo T . Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease. Int J Mol Sci. 2017; 18(9). PMC: 5618614. DOI: 10.3390/ijms18091965. View

Rosas-Hernandez H, Cuevas E, Raymick J, Robinson B, Sarkar S . Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction are Present in the Tg-SwDI Mouse Model of Alzheimer's Disease. Neuroscience. 2020; 440:48-55. DOI: 10.1016/j.neuroscience.2020.05.024. View

Carrano A, Hoozemans J, van der Vies S, van Horssen J, de Vries H, Rozemuller A . Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy. Neurodegener Dis. 2012; 10(1-4):329-31. DOI: 10.1159/000334916. View

10.

Jakel L, de Kort A, Klijn C, Schreuder F, Verbeek M . Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis. Alzheimers Dement. 2021; 18(1):10-28. PMC: 9290643. DOI: 10.1002/alz.12366. View

11.

Liu C, Yamazaki Y, Heckman M, Martens Y, Jia L, Yamazaki A . Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer's disease. Alzheimers Dement. 2020; 16(10):1372-1383. PMC: 8103951. DOI: 10.1002/alz.12104. View